Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fortress Biotech Inc (NQ: FBIO )

2.620 USD -0.210 (-7.42%)
Official Closing Price Updated: 7:13 PM EST, Nov 23, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 921,500
Open 2.800
Bid (Size) 2.630 (3)
Ask (Size) 2.660 (4)
Prev. Close 2.830
Today's Range 2.620 - 2.850
52wk Range 1.040 - 4.780
Shares Outstanding 52,902,146
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP Manufacturing Agreement for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
From GlobeNewswire News Releases
Fortress Biotech Ranked in Deloitte’s Technology Fast 500™ for the Second Year in a Row
From GlobeNewswire News Releases

Performance

YTD
-3.32%
-3.32%
1 Month
+3.97%
+3.97%
3 Month
-23.62%
-23.62%
6 Month
-12.67%
-12.67%
1 Year
+33.67%
+33.67%

More News

Read More
Fortress Biotech Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
From GlobeNewswire News Releases
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at the Society for Immunotherapy of Cancer (SITC) 35th Anniversary Annual Meeting
From GlobeNewswire News Releases
Mustang Bio Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
From GlobeNewswire News Releases
Checkpoint Therapeutics Reports Third Quarter 2020 Financial Results and Recent Corporate Highlights
From GlobeNewswire News Releases
Fortress Biotech Announces Oral and Poster Data Presentations at the 62nd American Society of Hematology (ASH) Annual Meeting
From GlobeNewswire News Releases
Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
From GlobeNewswire News Releases
Samsung Biologics and Checkpoint Therapeutics Expand Manufacturing Partnership for Cosibelimab
From PR Newswire
Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients with PSCA-positive Castration Resistant Prostate Cancer
From GlobeNewswire News Releases
Fortress Biotech’s Partner Company, Journey Medical Corporation, to be Featured in Webinar Hosted by ROTH Capital Partners
From GlobeNewswire News Releases
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.